Risk scores predicting disease progression in early-stage CLL: Comparative analysis and usefulness of IGHV subset #2 to improve their accuracy.

Autor: Arguello-Tomas M; Hospital de la Santa Creu I Sant Pau, Barcelona, Spain.; Facultat Medicina Universitat Autònoma Barcelona, Barcelona, Spain.; Institut de Recerca Sant Pau, Barcelona, Spain.; Institut Josep Carreras, Barcelona, Spain., Mozas P; Hospital Clínic Barcelona, Barcelona, Spain.; Institut Investigaciones Biomédicas August Pi i Sunyer, Barcelona, Spain., Albiol N; Hospital Clínic Barcelona, Barcelona, Spain.; Institut Investigaciones Biomédicas August Pi i Sunyer, Barcelona, Spain., López-Esteban M; Hospital General Universitario Gregorio Marañón, Madrid, Spain., Sierra J; Hospital de la Santa Creu I Sant Pau, Barcelona, Spain.; Facultat Medicina Universitat Autònoma Barcelona, Barcelona, Spain.; Institut de Recerca Sant Pau, Barcelona, Spain.; Institut Josep Carreras, Barcelona, Spain., Nomdedéu J; Hospital de la Santa Creu I Sant Pau, Barcelona, Spain.; Facultat Medicina Universitat Autònoma Barcelona, Barcelona, Spain.; Institut de Recerca Sant Pau, Barcelona, Spain., Martinez-Laperche C; Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Instituto de Investigación Gregorio Marañón, Madrid, Spain., Moga E; Hospital de la Santa Creu I Sant Pau, Barcelona, Spain.; Facultat Medicina Universitat Autònoma Barcelona, Barcelona, Spain.; Institut de Recerca Sant Pau, Barcelona, Spain., Piñeyroa JA; Hospital Clínic Barcelona, Barcelona, Spain.; Institut Investigaciones Biomédicas August Pi i Sunyer, Barcelona, Spain., Delgado J; Hospital Clínic Barcelona, Barcelona, Spain.; Institut Investigaciones Biomédicas August Pi i Sunyer, Barcelona, Spain.; Universitat de Barcelona, Barcelona, Spain., Osorio S; Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Instituto de Investigación Gregorio Marañón, Madrid, Spain., Moreno C; Hospital de la Santa Creu I Sant Pau, Barcelona, Spain.; Facultat Medicina Universitat Autònoma Barcelona, Barcelona, Spain.; Institut de Recerca Sant Pau, Barcelona, Spain.; Institut Josep Carreras, Barcelona, Spain.

Publikováno v: Cancer [Cancer] 2024 Sep 12. Date of Electronic Publication: 2024 Sep 12.

mRNA-1273 SARS-CoV-2 vaccine in recently transplanted allogeneic hematopoietic cell transplant recipients: Dynamics of cellular and humoral immune responses and booster effect.

Autor: Albiol N; Hematology Department, Hospital de la Santa Creu i Sant Pau, Carrer del Mas Casanovas 90, 08041 Barcelona, Spain; Josep Carreras Leukaemia Research Institute, Carrer de Sant Quintí 77-79, 08041 Barcelona, Spain; Institut d'Investigació Biomèdica (IIB) Sant Pau, Carrer de Sant Quintí 77-79, 08041 Barcelona, Spain; Autonomous University of Barcelona, Carrer de Sant Antoni Maria Claret 167, 08025 Barcelona, Spain; Catalan Institute of Oncology (ICO), Hospital Universitari Doctor Josep Trueta, 17007 Girona, Spain. Electronic address: nilalbiol@iconcologia.net., Lynton-Pons E; Institut d'Investigació Biomèdica (IIB) Sant Pau, Carrer de Sant Quintí 77-79, 08041 Barcelona, Spain; Autonomous University of Barcelona, Carrer de Sant Antoni Maria Claret 167, 08025 Barcelona, Spain; Immunology Department, Hospital de la Santa Creu i Sant Pau, Carrer del Mas Casanovas 90, 08041 Barcelona, Spain., Aso O; Hematology Department, Hospital de la Santa Creu i Sant Pau, Carrer del Mas Casanovas 90, 08041 Barcelona, Spain., Moga E; Josep Carreras Leukaemia Research Institute, Carrer de Sant Quintí 77-79, 08041 Barcelona, Spain; Institut d'Investigació Biomèdica (IIB) Sant Pau, Carrer de Sant Quintí 77-79, 08041 Barcelona, Spain; Autonomous University of Barcelona, Carrer de Sant Antoni Maria Claret 167, 08025 Barcelona, Spain; Immunology Department, Hospital de la Santa Creu i Sant Pau, Carrer del Mas Casanovas 90, 08041 Barcelona, Spain., Vidal S; Institut d'Investigació Biomèdica (IIB) Sant Pau, Carrer de Sant Quintí 77-79, 08041 Barcelona, Spain; Autonomous University of Barcelona, Carrer de Sant Antoni Maria Claret 167, 08025 Barcelona, Spain; Immunology Department, Hospital de la Santa Creu i Sant Pau, Carrer del Mas Casanovas 90, 08041 Barcelona, Spain., Gómez-Pérez L; Hematology Department, Hospital del Mar - Parc de Salut Mar, Passeig Marítim de la Barceloneta 25-29, 08003 Barcelona, Spain., Santiago JA; Institut d'Investigació Biomèdica (IIB) Sant Pau, Carrer de Sant Quintí 77-79, 08041 Barcelona, Spain; Immunology Department, Hospital de la Santa Creu i Sant Pau, Carrer del Mas Casanovas 90, 08041 Barcelona, Spain., Triquell M; Hematology Department, Hospital de la Santa Creu i Sant Pau, Carrer del Mas Casanovas 90, 08041 Barcelona, Spain., Roch N; Division of Infectious Diseases, Hospital de la Santa Creu i Sant Pau, Carrer del Mas Casanovas 90, 08041 Barcelona, Spain., Lázaro E; Hematology Department, Hospital de la Santa Creu i Sant Pau, Carrer del Mas Casanovas 90, 08041 Barcelona, Spain., González I; Hematology Department, Hospital de la Santa Creu i Sant Pau, Carrer del Mas Casanovas 90, 08041 Barcelona, Spain; Autonomous University of Barcelona, Carrer de Sant Antoni Maria Claret 167, 08025 Barcelona, Spain., López-Contreras J; Institut d'Investigació Biomèdica (IIB) Sant Pau, Carrer de Sant Quintí 77-79, 08041 Barcelona, Spain; Autonomous University of Barcelona, Carrer de Sant Antoni Maria Claret 167, 08025 Barcelona, Spain; Division of Infectious Diseases, Hospital de la Santa Creu i Sant Pau, Carrer del Mas Casanovas 90, 08041 Barcelona, Spain., Esquirol A; Hematology Department, Hospital de la Santa Creu i Sant Pau, Carrer del Mas Casanovas 90, 08041 Barcelona, Spain; Josep Carreras Leukaemia Research Institute, Carrer de Sant Quintí 77-79, 08041 Barcelona, Spain; Institut d'Investigació Biomèdica (IIB) Sant Pau, Carrer de Sant Quintí 77-79, 08041 Barcelona, Spain; Autonomous University of Barcelona, Carrer de Sant Antoni Maria Claret 167, 08025 Barcelona, Spain., Sierra J; Hematology Department, Hospital de la Santa Creu i Sant Pau, Carrer del Mas Casanovas 90, 08041 Barcelona, Spain; Josep Carreras Leukaemia Research Institute, Carrer de Sant Quintí 77-79, 08041 Barcelona, Spain; Institut d'Investigació Biomèdica (IIB) Sant Pau, Carrer de Sant Quintí 77-79, 08041 Barcelona, Spain; Autonomous University of Barcelona, Carrer de Sant Antoni Maria Claret 167, 08025 Barcelona, Spain., Martino R; Hematology Department, Hospital de la Santa Creu i Sant Pau, Carrer del Mas Casanovas 90, 08041 Barcelona, Spain; Josep Carreras Leukaemia Research Institute, Carrer de Sant Quintí 77-79, 08041 Barcelona, Spain; Institut d'Investigació Biomèdica (IIB) Sant Pau, Carrer de Sant Quintí 77-79, 08041 Barcelona, Spain; Autonomous University of Barcelona, Carrer de Sant Antoni Maria Claret 167, 08025 Barcelona, Spain., García-Cadenas I; Hematology Department, Hospital de la Santa Creu i Sant Pau, Carrer del Mas Casanovas 90, 08041 Barcelona, Spain; Josep Carreras Leukaemia Research Institute, Carrer de Sant Quintí 77-79, 08041 Barcelona, Spain; Institut d'Investigació Biomèdica (IIB) Sant Pau, Carrer de Sant Quintí 77-79, 08041 Barcelona, Spain; Autonomous University of Barcelona, Carrer de Sant Antoni Maria Claret 167, 08025 Barcelona, Spain. Electronic address: igarciaca@santpau.cat.

Publikováno v: Leukemia research [Leuk Res] 2023 Sep; Vol. 132, pp. 107347. Date of Electronic Publication: 2023 Jun 22.

Reversions of QuantiFERON-TB Gold Plus in tuberculosis contact investigation: A prospective multicentre cohort study.

Autor: Pérez-Recio S; Tuberculosis Unit, Department of Infectious Diseases, Bellvitge University Hospital-Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain., Grijota-Camino MD; Tuberculosis Unit, Department of Infectious Diseases, Bellvitge University Hospital-Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.; Department of Fundamental and Medical-Surgical Nursing, University of Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain., Anibarro L; Tuberculosis Unit, Department of Internal Medicine, Complexo Hospitalario Universitario de Pontevedra, Pontevedra, Spain., Rabuñal-Rey R; Infectious Diseases Unit, Department of Internal Medicine, University Hospital Lucus Augusti, Lugo, Spain., Sabria J; Tuberculosis Unit, Hospital Moisès Broggi, Sant Joan Despí, Barcelona, Spain., Gijón-Vidaurreta P; Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañon, Madrid, Spain.; Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain., Pomar V; Infectious Diseases Unit, Department of Internal Medicine, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., García-Gasalla M; Department of Internal Medicine, Hospital Universitari Son Espases, Palma, Spain.; Balearic Islands Health Research Institute (IdISBa), Palma, Spain., Domínguez-Castellano Á; Clinic Unit of Infectious Diseases and Preventive Medicine, Hospital Virgen Macarena, Sevilla, Spain., Trigo M; Microbiology Department, Complexo Hospitalario Universitario de Pontevedra, Pontevedra, Spain., Santos MJ; Tuberculosis Unit, Hospital Lucus Augusti, Lugo, Spain., Cebollero A; Department of Clinical Analysis, CLILAB Diagnostics Laboratory, Vilafranca del Penedés, Barcelona, Spain., Rodríguez S; Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañon, Madrid, Spain.; Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain., Moga E; Department of Immunology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain., Penas-Truque A; Tuberculosis Unit, Hospital Lucus Augusti, Lugo, Spain., Martos C; Tuberculosis Unit, Hospital Moisès Broggi, Sant Joan Despí, Barcelona, Spain., Ruiz-Serrano MJ; Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañon, Madrid, Spain.; Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.; Centro de Investigación Biomédica en Red (CIBER) de Enfermedades Respiratorias- CIBERES (CB06/06/0058), Madrid, Spain., Garcia-de-Cara EI; Department of Microbiology, Bellvitge University Hospital-Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain., Alcaide F; Department of Microbiology, Bellvitge University Hospital-Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.; Department of Pathology and Experimental Therapy, University of Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain., Santin M; Tuberculosis Unit, Department of Infectious Diseases, Bellvitge University Hospital-Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.; Department of Clinical Sciences, University of Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain.; Centre for Biomedical Research in Infectious Diseases Network (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.

Publikováno v: PloS one [PLoS One] 2023 Aug 30; Vol. 18 (8), pp. e0285917. Date of Electronic Publication: 2023 Aug 30 (Print Publication: 2023).

High Levels of Platelet-Lymphocyte Complexes in Patients with Psoriasis Are Associated with a Better Response to Anti-TNF-alpha Therapy

Autor: Sanz-Martinez, MT, Moga, E, Martinez, MAS, Atenza, CZ, Vidal, S, Juarez, C, Puig, L

Publikováno v: JOURNAL OF INVESTIGATIVE DERMATOLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

Psoriasis is currently considered to be an immune-mediated disease whose patho-mechanisms involve platelet activation, which seems to correlate with the activity of the disease. Platelet activation is associated with the formation of platelet-lymphoc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::c09fad5452813fc8f8c8d8870cbc59d2
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=1920

Comparison of a human acellular dermal matrix and a polypropylene mesh for pelvic floor reconstruction: a randomized trial study in a rabbit model.

Autor: Pero M; Department of Obstetrics and Gynecology, Hospital de La Santa Creu I Sant Pau, Biomedical Research Institute Sant Pau (IIB Sant Pau), Universitat Autònoma de Barcelona, Carrer Sant Quintí 89, 08041, Barcelona, Spain. mpero@santpau.cat., Castells-Sala C; Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain.; Barcelona Tissue Bank. Banc de Sang I Teixits (BST), Barcelona, Spain., Alserawan L; Department of Immunology, Hospital Clinic de Barcelona, Barcelona, Spain., Casani L; Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain., Juan Babot JO; Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain., Jorba I; Department of Biomedical Engineering, Institute for Complex Molecular Systems (ICMS), Eindhoven University of Technology, Eindhoven, The Netherlands., Pérez ML; Barcelona Tissue Bank. Banc de Sang I Teixits (BST), Barcelona, Spain.; Vall Hebron Institute of Research (VHIR), Barcelona, Spain., Moga E; Department of Immunology, Hospital de La Santa Creu I Sant Pau, Biomedical Research Institute Sant Pau (IIB Sant Pau), Universitat Autònoma de Barcelona, Barcelona, Spain., Otero J; Biophysics and Bioengineering Unit, University of Barcelona, Barcelona, Spain., López-Chicón P; Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain.; Barcelona Tissue Bank. Banc de Sang I Teixits (BST), Barcelona, Spain., Badimon L; Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain., Vilarrodona Serrat A; Barcelona Tissue Bank. Banc de Sang I Teixits (BST), Barcelona, Spain.; Vall Hebron Institute of Research (VHIR), Barcelona, Spain., Porta-Roda O; Department of Obstetrics and Gynecology, Hospital Universitari Mútua Terrassa, Universitat de Barcelona, Barcelona, Spain.

Publikováno v: Scientific reports [Sci Rep] 2022 Nov 30; Vol. 12 (1), pp. 20698. Date of Electronic Publication: 2022 Nov 30.